Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Abdominal Imaging|July 17, 2013
Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imagingMichele Di Martino, Rossella Di Miscio, Gianmaria De Filippis, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2011
Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerasesLaura Casu, Filippo Cottiglia, Marco Leonti, et al.
European Journal of Gastroenterology & Hepatology|January 29, 2015
MDCT classification of steatotic liver: a multicentric analysisLuca Saba, Michele di Martino, Sandro Bosco, et al.
Oncology (Williston Park, N.Y.)|February 1, 2024
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in ItalySonia La Spina, Paolo Scollo, Basilio Pecorino, et al.
Biomolecules|May 28, 2025
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD AssessmentGiovanni Luca Scaglione, Valentina Lombardo, Maurizio Polano, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 9, 2025
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody-drug conjugates: a narrative reviewGiuseppa Scandurra, Filippo Marano, Vittorio Gebbia, et al.
European Radiology|April 29, 2014
Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findingsMichele Di Martino, Luca Saba, Sandro Bosco, et al.
European Radiology|November 27, 2012
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imagingMichele Di Martino, Gianmaria De Filippis, Adriano De Santis, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 14, 2025
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT studyGiuseppa Scandurra, Giuseppe Scibilia, Valentina Lombardo, et al.
Pageof 3